Keratins K8 and K18 are the major components of the intermediate filament cytoskeleton of simple epithelia. Increased levels of these keratins have been associated with invasive growth and progression to malignancy in different types of human and murine epithelial tumors (including skin tumors), and even in tumors from nonepithelial origin. However, it has not yet clarified whether K8/K18 expression in tumors is cause or consequence of malignancy. Given the increasing incidence of epidermal cancer in humans (40% of all tumors diagnosed), we generated a mouse model to examine the role of simple epithelium keratins in the establishment and progression of human skin cancer. Transgenic mice expressing human K8 in the epidermis showed severe epidermal and hair follicle dysplasia with concomitant alteration in epidermal differentiation markers. The severity of the skin phenotype of these transgenic mice increases with age, leading to areas of preneoplastic transformation. Skin carcinogenesis assays showed a dramatic increase in the progression of papillomas toward malignancy in transgenic animals. These results support the idea that K8 alters the epidermal cell differentiation, favors the neoplastic transformation of cells, and is ultimately responsible of the invasive behavior of transformed epidermal cells leading of conversion of benign to malignant tumors.
gradually becoming replaced by K1/K10 in the suprabasal layers during terminal differentiation (1, 2) .
It is widely accepted that epidermal keratins are involved in the maintenance of epidermal structural integrity (3) . Recently, we and other authors have reported the involvement of K10 and K16 in the modulation of cell growth (4) (5) (6) (7) . The function of non-epidermal keratins (such as K8 and K18) is, however, less clear. Although one strain of K8 knockout mice (C57B1/6x129Sv mice) dies around day 12 due to a TNF-sensitive failure of trophoblast giant cell barrier function (8) , those with a different genetic background (FVB/N mice) survive to adulthood, although they suffer hepatic lesions, colorectal hyperplasia, and inflammation (9, 10) . K18 null mice are viable, and their liver morphology appears relatively normal, apart from accumulation of K8-containing Mallory bodies and formation of enlarged hepatocytes in aging mice (11) . Transgenic mice expressing a point-mutated K18 show liver inflammation and necrosis in association with hepatocyte fragility (12) . They are also more susceptible to hepatotoxic injury (13) . A role for K8 in polarization of simple epithelia has also been described (14) .
We earlier demonstrated the importance of K8 and K18 in the maintenance of the differentiation state of acinar cells in the exocrine pancreas (15) . Transgenic (TG) mice expressing human K8 (HK8)-TGHK8 mice-and with just a threefold increase in the amount of K8/K18 in their exocrine pancreas (compared with wild-type mice) show severe exocrine pancreatic abnormalities, such as the loss of cellular architecture, dysplasia, re-differentiation of acinar to ductal cells, and inflammation (15) . The phenotype of the TGHK8 mouse exocrine pancreas is very similar to that of transgenic mice expressing a dominant-negative mutant TGF-β Type II receptor (16) , which accordingly also show increased levels of K8 and K18 in their pancreatic acinar cells and suggests the involvement of these keratins in TGF-β signaling (15) . Other experimental findings have also suggested the implication of simple epithelial keratins in signaling, as shown by their interaction with different cytoplasmic proteins. In particular, the interaction of K18 with 14-3-3 proteins in a phosphorylation-dependent manner (17, 18) appears to partially modulate hepatocyte mitotic progression in association with alterations in the nuclear distribution of 14-3-3 proteins during mitosis (19) . In agreement with this observation, the distribution of the 14-3-3ζ protein in the liver of K8 null mice (lacking keratin K8/K18 filaments in hepatocytes) is different to that seen in wild-type animals (20) .
Therefore, although still poorly understood, growing evidence correlates altered patterns of keratin expression with perturbations in cell growth and differentiation. In this context, a wellknown but unexplained clinical phenomenon is the aberrant expression of simple epithelium keratins by different types of human carcinoma of stratified epithelial origin, e.g., oral and skin cancers. A positive correlation has been established between the presence of these keratins and tumor malignancy both in vitro (21) and in vivo (22) (23) (24) . Even more intriguing is the aberrant expression of K8 and K18 in human tumor cells of different non-epithelial origins, such as malignant melanoma and lymphoma, which normally only express Type III IF vimentin (25, 26) .
Our study aimed to determine whether a causal relationship exists between the abnormal expression of simple epithelium keratins and the development of neoplastic characteristics. We chose the skin due to the alarming increase in the incidence of epidermal tumors in humans over recent years [basal cell carcinomas and squamous cell carcinomas make up the vast majority of malignant tumors diagnosed (27) ].
The epidermis is a multi-layered epithelium consisting of proliferating and differentiated keratinocytes. During the development of mammalian skin, epithelial cells from the basal layer of the developing epidermis, in complex interactions with the underlying dermis, give rise to the hair follicles. These structures play a major role in the development of skin cancer. Hair follicles contain at least six or seven different epithelial cell types arranged as concentric cylinders. Once established, hair follicles undergo a life-long cyclic transformation from a resting (telogen) phase, to a new growth (anagen) phase (with rapid proliferation of the follicular keratinocytes and elongation and thickening of the hair shaft), followed by a regression (catagen) phase leading to the involution of the hair follicle (28, 29) . In each new cycle, the hair-forming compartments of the follicle are regenerated in a process that recapitulates many of the stages of follicular neogenesis.
Although K8/K18 are not typically expressed in the epidermis, sporadic hair follicles have been found to express K8. In spite of the remarkable association between the expression of simple epithelium keratins and epidermal neoplasia (22) (23) (24) , transgenic mice expressing K18 in the basal layer of the epidermis are completely normal (30) . However, since K8 and K18 do not appear to have similar properties [the overexpression of K18 in transgenic mice causes no overt phenotype (31) , while TGHK8 mice show severe alterations leading to death in those expressing high levels of HK8 (15)], we sought to analyze the consequences of simple epithelium K8 expression in the epidermis and to determine its relationship with skin cancer and tumor progression. Given that TGHK8 mice with high transgene copy numbers and greater protein expression show ectopic expression of HK8 in the skin, they provide an excellent model for this purpose (15, 32) . Our findings show that the expression of HK8 in the skin results in severe alterations in the morphology and differentiation of the epidermis and hair follicles. Moreover, aging mice develop areas of preneoplastic transformation and, in mouse skin carcinogenesis assays, epidermal K8 expression dramatically increased epithelial progression toward malignancy.
MATERIALS AND METHODS

Transgenic mice
The animals used in this study were TGHK8 transgenic mice -(TGHK8-4 and TGHK8-8 lines) and their control nontransgenic littermates. These animals have been described in previous papers (15, 32) .
Preparation and analysis of RNA
Total RNA from different tissues was purified and Northern blot analysis performed as described (15) . The probes used for HK8, mK8, and mK18 have been described previously (15) . As a loading control, the filters were stripped and rehybridized with a ribosomal 7S probe.
Histological and immunohistochemical analysis
Freshly collected tissues were immediately fixed in 10% formaldehyde for histological analyses, or 70% ethanol for immunohistochemical analyses. They were then embedded in paraffin wax, sectioned, and stained with hematoxylin/eosin. Immunohistochemistry was performed on deparaffinated sections using antibodies against mouse K8 (the rat monoclonal antibody [mAb] TROMA-1 which also recognizes the human K8) (32); human K8 (CAM 5.2 mAb, Becton Dickinson, San Jose, CA ), K5, K6, K14, loricrin, filaggrin, and involucrin (Covance-Babco, Denver PA); K10 (K8.60 mAb; Sigma, St. Louis, MO), and α6 integrin, a rat anti mouse monoclonal antibody (Chemicon, Temecula, CA). We used secondary biotinylated antibodies (Jackson Immunoresearch Laboratories, West Grove, PA), followed by streptavidin conjugated to horseradish peroxidase (Dako, Carpinteria, CA). Control immunostaining using the secondary antibody in the absence of the primary antibody were performed routinely. Antibody localization was determined using 3,3-diaminobenzidine (DAB) in PBS.
Immunofluorescence analysis
Paraffin sections of formalin-fixed dorsal skin samples of newborn wild-type and transgenic mice were incubated with TROMA 1 and antiK14 antibodies as described (32) . Staining of wildtype samples showed positive staining with K14 and no signal with TROMA 1 antibody. Controls were included to assess nonspecific immunofluorescence staining.
Transmission electron microscopy (TEM)
Samples from the dorsal skin of adult transgenic and nontransgenic littermates were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.5) and postfixed in 1% osmium tetroxide prior to dehydration and embedding in Epon 812 resin. Semithin sections were stained with 1% toluidine blue for field selection. Ultrathin sections were stained with uranyl acetate and lead citrate.
Morphometric studies
Measurements were performed on 4-µm paraffin sections stained with hematoxylin-eosin. Samples were obtained during the first postnatal hair cycle (from at least three wild-types and three transgenic mice on postnatal days 0, 7-10, and 22). Five representative skin sections from each mouse were analyzed. The number of hair follicles per millimeter was determined by counting only those with at least one-third of their length in the section (magnification ×100, 30 fields per time point). Epidermal and subcutaneous thicknesses were measured at magnification ×200 (15 fields per time point). Hair follicle thickness was measured at the region of greatest hair bulb diameter (Auber's line). Statistical analyses were performed with the two-tailed unpaired Student's t-test using the statistical program Systat 11.0 (SPSS Inc., Chicago, IL).
In vivo proliferation study
Wild-type and transgenic mice received an intraperitoneal injection of BrdU (120 mg/kg body weight; Boehringer Mannheim GmbH) in 0.9% NaCl; animals were sacrificed 2 h later. Skin was fixed in 70% ethanol for 72 h, embedded in paraffin, sectioned, and sequentially incubated for 1 h with an antiBrdU rat mAb (kindly provided by S. Mittnacht) and a biotinylated secondary anti-rat antibody to label S-phase cells. We counted only labeled cells contained in interfollicular epidermis.
Tumor assays
For in vivo chemical carcinogenesis studies, female homozygous v-Ha-ras transgenic Tg.AC mice (33) were mated with TGHK8-4 and TGHK8-8 males (15) . Double transgenics (named TGHK8xHa-ras) were identified by Southern blot and caged separately from hemizygous Tg.AC animals not carrying the HK8 transgene (named wild-typexHa-ras). The latter animals were used as controls. Double transgenic mice (n=34) and controls (n=30) 7-weeks old were treated twice weekly with topical applications of 5 µg of TPA (12-O-tetradecanoylphorbol-13 acetate) in 200 µl acetone for 7 weeks, according to standard protocols (34) along 5 different carcinogenesis assays. Tumor incidence was observed weekly, starting 5 weeks after TPA promotion for every assay. Growth and progress toward malignancy were recorded, and a subset of tumors was examined histologically. The medians of tumor variables from the five experiments of carcinogenesis were compared by the non-parametric Mann-Whitney W (Wilcoxon) test.
RESULTS
Expression of the HK8 transgene in mouse epidermis
We previously reported the generation of 8 transgenic lines (TGHK8-1 to TGHK8-8) containing a 12 kb genomic fragment of the human K8 locus (15, 32) . Lines of transgenic mice with high transgene copy number and high protein expression (TGHK8-4 and TGHK8-8 lines) have a physical appearance characterized by somewhat erect hair and reduced growth. Although the transgene mostly showed tissue-specific expression, high-expressing transgene lines also express K8 in the basal layer of the stratified epithelium, including the epidermis and hair follicles of the back skin (32) . In this study we have analyzed both lines (TGHK8-4 and TGHK8-8); since the results obtained were similar for both, they are presented generically as for "TGHK8" or "transgenic" mice.
Expression of the transgene was examined by Northern blotting of RNA samples from the back skin of transgenic mice (Fig. 1 ). Human K8 RNA was detected in all TGHK8 mice. Mouse K8/K18 RNA was not detected in the back skin of either wild-type or transgenic mice. It is worth mentioning that HK8 RNA expression levels in the skin of the TGHK8 mice were comparable with levels in their liver.
The skin is made up of many cell types. To examine the cell-type specific expression pattern of the transgene in epidermis and hair follicles, we performed immunohistochemical analyses of newborn mice ( Fig. 2A, B) . As expected, mouse K8 (mK8) protein was not expressed in the skin of wild-type not in transgenic mice, although it was sporadically detected in some hair follicles (data not shown). The presence of the HK8 in transgenic mice was mainly confined to the basal layer of the epidermis (sporadically we observed HK8 expression in some suprabasal cells) and to the outer root sheath (ORS) of the hair follicles (Fig. 2B) . However, in a subset of TGHK8 mice, interfollicular K8 expression was progressively lost as they grew, with staining restricted to hair follicles and interfollicular epidermis adjacent to areas of hair emergence (data not shown).
We next examined whether HK8 expression affects the endogenous cytoskeleton of epidermal cells (Fig. 2C-F ) and the normal histology of skin (Fig. 2I-N') . The expression patterns of other keratins in the skin of newborn wild-type and transgenic mice are depicted in Fig. 2C-F . The expression pattern of HK8 in the skin of the transgenic mice (Fig. 2B) paralleled that of K5 in the skin of the wild-type animals (Fig. 2C) , although the transgenic keratin in the interfollicular epidermis stained weakly compared with that of K5. Interestingly, the expression of HK8 in TGHK8 mice partially replaced that of K5 in the bulb of the hair follicle (Fig. 2B-D) . Mouse K14 (mK14) staining did not differ between wild-type and transgenic skin (Fig. 2E, F,  respectively) . Double immunofluoresence analysis showed that HK8 in basal layer keratinocytes appeared to co-localize with mK14 (Fig. 2G, H) . Similar results were obtained using simultaneous immunohistochemistry staining (data not shown). Considering that K14 is the only type I keratin expressed in the basal layer of interfollicular epidermis, a K8/K14 pair is the most plausible filament composition. HK8 appears in a filamentous state since we do not detect keratin aggregates. This observation was straightened by TEM studies of wild-type and TGHK8 back skin samples of adult wild-type and TGHK8 mice that showed the absence of aggregates or dots in the cells and the presence of filamentous keratin throughout the cytoplasm (Fig. 3A, C) . These studies also reveal a moderate hyperplasia in interfollicular epidermis of transgenic mice (Fig. 3C ) that was extensively studied by histological procedures in Fig. 2I -N'. In addition, corneal envelope showed enlarged electrondense areas in transgenic mice, suggesting scattered points of parakeratosis (Fig. 3E) . No alterations in desmosomes or other epithelial components, i.e., keratohialin granules and intercellular spaces were found in the TGHK8 epidermis (Fig. 3A,  C) .
Progressive phenotype of epidermal hyperplasia and dysplastic hair follicles in TGHK8 transgenic mice
Histological studies of neonatal skin showed no major differences between TGHK8 transgenic mice and their wild-type littermates, although detailed histomorphometric analysis revealed that TGHK8 transgenic mice had a significantly lower number of hair follicles per mm at birth (Fig.  4, A) . This difference disappeared when the mice reached 7 to 10 days of age. These results indicate a delay occurs in hair follicle development at birth, although a few days later all hairs appear normal. Hair growth delay at birth was concomitant with a significant thinning of the hypodermis in TGHK8 mice (Fig. 4B ).
Although at 7 to 10 days of age most anagen hair follicles were virtually normal in transgenic mice, important morphological alterations in skin physiology became apparent: a few dysplastic hair follicles were noticeable (Fig. 2J) and, in addition, scattered areas of epidermal hyperplasia (involving an expansion of both the spinous and granular layers) were observed in regions of dysplastic hair emergence (Fig. 2J) . Histomorphometic analysis of skin shows that hair follicle thickness was significantly greater in the transgenic mice ( Fig. 4D ) with no differences in the other parameters analyzed (Fig. 4A-C) . Thus, hair growth delay observed at birth in TGHK8 mice was not only completely overcome but that hair growth accelerated in 7-to 10-day-old mice.
At 22 days of age, the transgenic mice showed a severe skin phenotype. Epidermal hyperplasia affected extensive areas of their skin and was associated with an increased number of dysplastic hair follicles with twisted, irregular contours that were sometimes encysted and showed a lack of differentiation between inner and outer root sheaths (Fig. 2K, L) . Morphometric analysis indicated a striking increase (almost twofold) in the epidermal thickness of the TGHK8 mice (Fig. 4C ) compared with their wild-type littermates.
Worsening of the skin phenotype was very clear in 31-day-old and older TGHK8 mice. Extensive areas of severe epidermal hyperplasia associated with orthokeratotic hyperkeratosis were observed (Fig. 2M, N) . Some eosinophilic focal points of parakeratosis were evident (Fig.  2, N' ).
Interestingly, 31-day-old TGHK8 mice also showed an important delay in the hair cycle. At this age, wild-type animals entered the second hair cycle, and most of their hair follicles were in the anagen phase (Fig. 2M) . In contrast, TGHK8 mice showed a hair cycle delay, and, in areas of epidermal hyperplasia, the hair follicles remained in the telogen phase and any hair follicles entering the anagen phase of the second hair cycle were hard to find (Fig. 2N) . Although the severity of the phenotypic features described above varied among different animals of the same line, progressive worsening was always seen with aging.
Terminal differentiation is altered in the transgenic mouse epidermis
The histological changes observed in TGHK8 mice skin suggest that a disruption of the normal epidermal differentiation program occurs in these animals. Markers for early and late terminal differentiation were therefore studied. Although wild-type mouse epidermis expressed K5 in the basal layer and ORS of the hair follicles (Fig. 5A ), TGHK8 mouse dysplastic hair follicles lost their K5 expression (Fig. 5B) . Instead, these aberrant hair follicles showed a robust expression of HK8 (Fig. 5B') , as well as markers of terminal differentiation (see below). Although K10 suprabasal staining was positive in the interfollicular epidermis and neck of hair follicles in wildtype mice (Fig. 5C ), K10 expression was seen in an increased number of suprabasal cell layers (due to epidermal hyperplasia) adjacent to the emergence area of dysplastic hair follicles and in the dysplastic hair follicles of the transgenic mice (Fig. 5D) .
Analysis of late markers of terminal differentiation included immunohistochemical detection of filaggrin, loricrin, and involucrin. Filaggrin, an intermediate filament-associated protein, was specifically expressed in wild-type mice in the granular cells of the epidermis (Fig. 5E) . In transgenic mice, however, filaggrin-positive cells also covered the dysplastic hair follicles (Fig.  5F ). Staining for loricrin and involucrin, major precursors of the cornified envelope, revealed the abnormal expression of these proteins in the skin of transgenic mice. Therefore, both the dysplastic hair follicles and the hyperplastic epithelium bordering show a marked expression of loricrin (Fig. 5H) . Involucrin expression was also increased in the dysplastic hair follicles of the transgenic mice (Fig. 5J) . Since hair follicles are the site of origin of many skin tumors, we consider very relevant the altered differentiation pattern found in those of TGHK8 mice. Therefore, we have investigated other markers of altered proliferation/differentiation program. Keratins K6 and K16, which are not normally expressed in the interfollicular epidermis, are considered sensitive indicators of an altered epidermal differentiation program, such as in hyperproliferation or wound healing (35, 36) . Positive staining for K6 expression in the wildtype mice was limited to the innermost layer of the ORS of the hair follicles (Fig. 5K) . However, in TGHK8 mice, K6 was expressed in all the epithelial layers of the dysplastic hair follicles (Fig.  5L) . Curiously, the interfollicular epidermis of TGHK8 mice did not express K6, indicating that the observed hyperplasia could be due to improper differentiation rather than hyperproliferation. To assess this, epithelial cell proliferation in interfollicular epidermis of skin from wild-type (n=3) and TGHK8 (n=4) of 22-and 31-day-old mice was analyzed by bromodeoxyuridine labeling. No significant differences were found between wild-type and transgenic mice at these ages (data not shown).
HK8 expression in the skin of transgenic mice induces preneoplastic transformation of epidermis in aging mice and increases the malignant progression of skin tumors
As previously shown (Fig. 2) , TGHK8 mice develop a striking progressive phenotype of hyperplasia and hair follicle dysplasia, the severity of which increases with age. Therefore, in 1-year-old transgenic mice (and even in younger ones, Fig. 6B) , epidermal hyperplasia has shown to evolve to preneoplastic changes in some regions. These appeared as pseudocarcinomatous hyperplasia (Fig. 6B) or areas with severe dysplastic changes and skin atypia associated with an accumulation of aberrant hair follicles (Fig. 6C) . This observation prompted us to investigate the susceptibility of TGHK8 mice to develop skin cancer. As transgenic mice do not develop spontaneous tumors, a chemical skin carcinogenesis protocol was performed. Tumors were induced by TPA treatment in F1 crosses of TGHK8 mice with a transgenic strain (Tg.AC) carrying a mutant Ha-ras transgene that triggers the classic initiation event (34) . All groups of mice developed papillomas with a similar latency period (5-7 weeks). Macroscopic analysis of the tumors at all times during and after TPA treatment showed that the percentage of animals that develop tumors was similar in both, the wild-typexHa-ras and transgenicxHa-ras mice (Fig.  6D) , although tumor multiplicity (number of tumors per mouse) was significantly reduced in TGHK8xHa-ras mice (Fig. 6E) . When the tumors first appear, they were classified as benign papillomas by histological analysis (data not shown), having similar size and displaying an exophytic growth in both groups of mice, TGHK8xHa-ras and wild-typexHa-ras. However, soon after, at 12 weeks of promotion, the tumors of TGHK8-Ha-ras mice often begun to change their physical appearance, showing an endophytic growth not observed in the papillomas of the wild-type mice, which continued growing in an exophytic way (Fig. 6G) . The histopathological examination of tumors from wild-typexHa-ras and transgenic-Ha-ras mice 20-27 weeks after the promotion protocol showed in TGHK8xHa-ras mice a significantly higher incidence of malignant progression (Fig. 6F) , measured as the frequency of appearance of focal invasive areas, i.e., microinvasive infiltration (Fig. 6I) and in situ carcinomas. In TGHK8xHa-ras mice, a few tumors left to develop until week 32-33 became very aggressive, undifferentiated, squamous cell carcinomas (SCCs). Conversion had not occurred in wild-type mouse tumors by this time (data not shown). In addition to the histological analysis, α6 integrin expression was used as a marker of malignancy (Fig. 6 J, K) . The immunostaining of wild-typexHa-ras and TGHK8xHa-ras tumors shows a disseminated expression of a-α6 integrin in the basal and suprabasal layers of the TGHK8xHa-ras mouse derived tumor (Fig. 6J ) compared with the basal localization of α6 integrin in wild-typexHa-ras tumors (Fig. 6K) . The disseminated expression of α6 integrin corroborates the malignant phenotype of TGHK8xHa-ras tumors found by histopathological analysis. HK8 staining with human K8 specific antibody CAM 5.2 of TGHK8xHa-ras tumors shows the mosaic expression of the transgenic keratin (Fig. 6L, M) . This result is in accordance with that obtained from the staining of adult interfollicular skin, where we observed a discontinuous HK8 expression (see above). HK8 expression is more extensively detected in undifferentiated basal regions of the tumor (Fig. 6L ). An extreme case of mosaicism showing the absence of HK8 in more differentiated, benign regions of the tumor and a robust staining in the invasive area is presented in Fig. 6M .
DISCUSSION
Keratin K8 is considered as a marker of malignancy in skin tumors, including human cancer. Increased levels of simple epithelium keratins in invasive tumors of different origin, including skin cancer, had previously been understood as a consequence of malignancy. No causative role for K8/K18 in tumorigenesis had yet been identified. In adults, K8/K18 form the major intermediate filaments in simple epithelial tissues but are not normally expressed in stratified epithelia. In skin, K8 and K18 are not detected in epidermis; however, the ORS cells of the hair follicle may sporadically express K8 and Merkel cells are K8/K18 positive (37) . We generated transgenic mice that ectopically express the human K8 gene in the basal layer of the epidermis and hair follicles. The resulting TGHK8 mice showed a striking progressive phenotype of hyperplasia and hair follicle dysplasia that frequently developed into premalignant areas in aging animals. They also showed abnormal epidermal differentiation and a dramatic increase in the malignant progression of skin tumors in chemical skin carcinogenesis assays. Together, these results support the hypothesis that the expression of K8 in skin impairs the normal regulation of epidermal morphogenesis and is ultimately responsible for the invasive behavior of transformed epidermal cells.
Inappropriate expression of K8 in skin causes alterations in hair follicle morphogenesis and the hair growth cycle
This study shows that the presence of K8 in skin is far from innocuous. Although K8 colocalized with K14 to form normal keratin filaments in vivo in these transgenic mice (Figs. 2G, H; 3A) and even though no aggregates of K8 are detected, TGHK8 mice showed important perturbations of skin homeostasis. The first sign of abnormalities is seen at birth: a delay in hair follicle morphogenesis (Fig. 4A) . A delay in the second postnatal hair growth cycle also occurs (Fig. 2N) .
Alterations in the hair follicle cycle have also been observed in transgenic mice expressing K16 in basal keratinocytes and hair follicles and in those overexpressing this keratin (4, 38) . Both these and the present results suggest the importance of suitable keratin expression patterns in hair follicles if the hair cycle is to proceed correctly.
The expression of K8 in skin interferes with normal differentiation of the epidermis and hair follicles
The TGHK8 mice showed epidermal hyperplasia plus alterations in keratinocyte terminal differentiation, as demonstrated by the expression pattern of differentiation markers. Further, the aberrant expression of K6 in dysplastic hair follicles, without increasing their proliferative rate, suggests they follow an alternative pathway of keratinocyte differentiation. Other authors in other systems (39) have also proposed a similar mechanism. Therefore, the present results indicate that the expression of K8 in skin abrogates the differentiated status of epidermal and follicular cells. An altered pattern of cell differentiation was also found in the acinar cells of the exocrine pancreas of TGHK8 mice, which show pancreatic tissue de-differentiation soon after birth, plus signs of loss of pancreatic tissue architecture and dysplasia (15) . Thus, in both tissues, epidermis (including hair follicles) and exocrine pancreas, K8 expression is disregulated, causing a progressive phenotype of cellular dysplasia that eventually may evolve to areas of premalignant lesions (15, and Fig. 6B, C) . This is interesting because hair follicles are self-renewing and contain reservoirs of multipotent stem cells that can regenerate the epidermis. Further, they are the site of origin of many neoplasms, including carcinomas and pilomatricomas. These diseases arise through the inappropriate activation of signaling pathways that regulate hair follicle morphogenesis and the hair cycle (40) . The identification of the possible alterations in signaling molecules and pathways that lead to the dysplastic hair follicles in TGHK8 mice is currently underway in our laboratory. This will help in the understanding of pathogenic states in the skin associated with epidermal hyperplasia and dysplastic changes and may ultimately lead to the development of new therapies for skin tumors as well as for hair loss disease.
K8 expression in the skin of transgenic mice induces preneoplastic areas in aging mice and increases the malignant progression of skin tumors
K8 expression is naturally associated with cells with great proliferation potential, such as those of embryonic structures, the latter stages of cancer, or Bowen's skin lesions (2, 23, 41) . In addition, it has been reported that K8 are induced by v-ras in transformed epidermal keratinocytes (42, 43) . Also, the K8 gene is induced by EGFR activation (44) , which is EGFR overexpressed in both human and mouse epidermal tumors (45, 46) ; whereas the abrogation of EGFR function inhibits tumor development (34) . It has also been described that many tumors change their pattern of keratin expression and parallel those changes in their state of differentiation (47) . Therefore, K8 and K18 expression is increased during the progression of mouse epidermal tumors, whereas these keratins are absent in benign papillomas: K8 is localized in the less differentiated areas of tumors, while K10 is absent in those areas. Moreover, a positive correlation is found between the expression of simple epithelium keratins and epidermal malignancy, both in vitro (21) and in vivo (22, 23) . In this context, a causal relationship between the expression/silencing of an epidermal keratin gene and tumor features has been very recently established by our group (7) . Therefore, we have described that the expression of K10 in the proliferative basal layer of the epidermis, which in normal skin is expressed in suprabasal, postmitotic epidermal cells, prevents skin tumorigenesis (7) . Because K1/K10 expression is lost during skin tumor progression, these results suggest that K10 may function as a tumor suppressor.
The present study shows that TGHK8xHa-ras mice develop a reduced number of papillomas in mouse skin carcinogenesis experiments (Fig. 6E) . In contrast, these mice show a dramatic increase in multiplicity of malignant neoplasias (in situ carcinomas, microinvasive areas and SCCs; Fig. 6F )-something rarely seen in wild-typexHa-ras animals. This finding suggests that the number of cells susceptible to carcinoma formation is increased in TGHK8xHa-ras mice. The follicular origin of epidermal tumors has been reported (48) ; therefore, the diminished number of papillomas developed by TGHK8xHa-ras transgenic mice might be explained by the presence of their many aberrant hair follicles. However, different studies indicate that malignant vs. benign keratinocyte tumor formation is likely to involve distinct target cell populations with different commitment to differentiation (49) (50) (51) . It has also been reported that carcinomas in mice originate from stem cells resident in hair follicles (51) . Given the dramatic alterations in the pattern of hair follicle differentiation seen in TGHK8 mice, the size of hair follicle keratinocyte populations with high growth/differentiation potential might be increased in the skin of transgenic mice. This condition would explain the enhanced susceptibility progression toward malignancy seen in their tumors. Future research will characterize the proliferation and differentiation potentials, as well as the clonogenic capacity, of TGHK8xHa-ras mice keratinocytes.
Keratins are used in the diagnosis and prognosis of tumors of epithelial and non-epithelial origin. Proteolytic fragments of K8 and K18 (most likely through apoptotic cleavage) are components of the tissue polypeptide antigen, found in large amounts in the serum of patients with a wide range of carcinomas, and, their concentration correlates with survival of these patients (52, 53) . Beyond the diagnostic use of K8 and K18, the functional significance of this correlation is not clear. Our results indicate that K8/K18 expression takes place in carcinomas not simply because the regulation of K8/K18 gene expression uses oncogene activated transcription factors but rather they suggest that the malignant skin phenotype may be a direct consequence of K8 expression by itself or an indirect result of perturbations originated in other molecules/pathways by inappropriate K8 expression. Further studies are required to discover the signaling pathways involved. -type (A, C, E, G, I, K) and TGHK8 mice (B, D, F, H, J, L) . A, B) K5 detection. Arrows in (B) depict the absence of K5 expression in dysplastic hair follicles of transgenic mice, while they show a strong expression of HK8 (CAM 5.2 staining, arrows in B). In addition to the K10 suprabasal expression observed in wild-type mice (C), TGHK8 mice show K10 expression around the aberrant hair follicles (arrows in D). Filaggrin, involucrin, and loricrin were detected in the outermost suprabasal layers of interfollicular epidermis in wild-type mice (E, G, I). In contrast, staining for these three proteins revealed abnormally increased expression in TGHK8 mice, involving the dysplastic hair follicles (arrows in F, H, J). Increased loricrin staining was also observed in the interfollicular epidermis of TGHK8 mice (H). K6 was expressed in the innermost layer of the ORS of hair follicles in wild-type mice (K), whereas in dysplastic hair follicles of transgenic mice it was detected in all epithelial layers (arrows in L). Scale bars: (A-L) 50 µm. 
